ARSENIC TRIOXIDE TARGETS BCL6 FOR DEGRADATION AND INHIBITS THE PROLIFERATION OF BCL6-DEPENDENT DIFFUSE LARGE B-CELL LYMPHOMA

被引：0
|
作者：
Tse, E. [1 ]
Yue, K. [1 ]
Chau, D. [2 ]
Kwong, Y. -L. [1 ]
机构：
[1] Univ Hong Kong, Dept Med, Hong Kong, Hong Kong, Peoples R China
[2] Univ Hong Kong, Med, Hong Kong, Hong Kong, Peoples R China
来源：
HAEMATOLOGICA | 2017年 / 102卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
E1392
引用
收藏
页码：571 / 571
页数：1
相关论文
共 50 条
  • [21] Coexistent Rearrangements of c-MYC, BCL2, and BCL6 genes in a diffuse large B-cell lymphoma
    Ueda, C
    Nishikori, M
    Kitawaki, T
    Uchiyama, T
    Ohno, H
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2004, 79 (01) : 52 - 54
  • [22] BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphomas (DLBCL)
    Akyurek, N.
    Uner, A.
    Benekli, M.
    Barista, I.
    MODERN PATHOLOGY, 2010, 23 : 283A - 283A
  • [23] BCL2, BCL6, and MYC Rearrangements in Diffuse Large B-Cell Lymphomas (DLBCL)
    Akyurek, N.
    Uner, A.
    Benekli, M.
    Barista, I.
    LABORATORY INVESTIGATION, 2010, 90 : 283A - 283A
  • [24] Primary cutaneous diffuse large B-cell lymphoma, leg type with MYC/BCL2/BCL6 overexpression
    Okada, Yosuke
    Sone, Takehiro
    Takada, Kohei
    Ogata, Hiraku
    Saito, Keita
    Kimura, Fumihiko
    EJHAEM, 2022, 3 (01): : 251 - 251
  • [25] Targeting BCL6 in diffuse large B-cell lymphoma: what does this mean for the future treatment?
    Cerchietti, Leandro
    Melnick, Ari
    EXPERT REVIEW OF HEMATOLOGY, 2013, 6 (04) : 343 - 345
  • [26] A mouse model of diffuse large B-cell lymphoma induced by deregulated BCL6 expression.
    Cattoretti, G
    Pasqualucci, L
    Ballon, G
    Tam, W
    Murty, VV
    Morse, HC
    Dalla-Favera, R
    BLOOD, 2003, 102 (11) : 136A - 136A
  • [27] A complex case of BCL6 rearrangements in diffuse large cell lymphoma
    Cunningham, J
    Stranks, G
    O'Connor, M
    Sales, M
    Kernohan, N
    Pratt, N
    JOURNAL OF MEDICAL GENETICS, 2002, 39 : S51 - S51
  • [28] Prognostic significance of BCL6 and BCL2 expression in diffuse large B cell lymphoma (DLBCL)
    Dominic, Joseph F.
    Sharma, Atul
    Sharma, M. C.
    Karak, A. K.
    Kochupillai, Vinod
    Kalaivani, M.
    ANNALS OF ONCOLOGY, 2006, 17 : 201 - 201
  • [29] Development of a Novel B-Cell Lymphoma 6 (BCL6) PROTAC To Provide Insight into Small Molecule Targeting of BCL6
    McCoull, William
    Cheung, Tony
    Anderson, Erica
    Barton, Peter
    Burgess, Jonathan
    Byth, Kate
    Cao, Qing
    Castald, M. Paola
    Chen, Huawei
    Chiarparin, Elisabetta
    Carbajo, Rodrigo J.
    Code, Erin
    Cowan, Suzanna
    Davey, Paul R.
    Ferguson, Andrew D.
    Fillery, Shaun
    Fuller, Nathan O.
    Gao, Ning
    Hargreaves, David
    Howard, Martin R.
    Hu, Jun
    Kawatkar, Aarti
    Kemmitt, Paul D.
    Leo, Elisabetta
    Molina, Daniel M.
    O'Conne', Nichole
    Petteruti, Philip
    Rasmusson, Timothy
    Raubo, Piotr
    Rawlins, Philip B.
    Ricchiuto, Piero
    Robb, Graeme R.
    Schenone, Monica
    Waring, Michael J.
    Zinda, Michael
    Fawell, Stephen
    Wilson, David M.
    ACS CHEMICAL BIOLOGY, 2018, 13 (11) : 3131 - 3141
  • [30] Mutational, immune microenvironment, and clinicopathological profiles of diffuse large B-cell lymphoma and follicular lymphoma with BCL6 rearrangement
    Carreras, Joaquim
    Ikoma, Haruka
    Kikuti, Yara Yukie
    Miyaoka, Masashi
    Hiraiwa, Shinichiro
    Tomita, Sakura
    Kondo, Yusuke
    Ito, Atsushi
    Nagase, Shunsuke
    Miura, Hisanobu
    Kawada, Hiroshi
    Roncador, Giovanna
    Campo, Elias
    Hamoudi, Rifat
    Nakamura, Naoya
    VIRCHOWS ARCHIV, 2024, 484 (04) : 657 - 676
12345